BERNHAGEN; JURGEN

Patent Applications and Registrations

Patent applications and USPTO patent grants for BERNHAGEN; JURGEN.The latest application filed is for "amyloid inhibitory peptides".

Company Profile

0.12.15

BERNHAGEN; JURGEN - MUNCHEN DE
Bernhagen; Jurgen - Aachen DE
Bernhagen; Jurgen - New York NY
Bernhagen; Jurgen - Tubingen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Amyloid Inhibitory Peptides App 20210340180 - KAPURNIOTU; APHRODITE ; et al.	2021-11-04
Anti-MIF antibodies Grant RE43,497 - Brunner , et al. June 26, 2	2012-06-26
Inhibition Of Migration Inhibitory Factor In The Treatment Of Diseases Involving Cytokine-mediated Toxicity App 20120149044 - Bucala; Richard J. ; et al.	2012-06-14
Inhibition Of Migration Inhibitory Factor In The Treatment Of Diseases Involving Cytokine-mediated Toxicity App 20120028281 - Bucala; Richard J. ; et al.	2012-02-02
Methods Of Treating Inflammation App 20110262386 - Bernhagen; Jurgen ; et al.	2011-10-27
Methods And Compositions For Treating Atherosclerosis And Related Condidtions App 20110070184 - Bernhagen; Jurgen ; et al.	2011-03-24
Methods Of Treatment Using Anti-mif Antibodies App 20110044988 - Bernhagen; Jurgen ; et al.	2011-02-24
Chemically Modified Peptide Analogs App 20100221240 - Kapurniotu; Afroditi ; et al.	2010-09-02
Method for determining MIF content App 20100184091 - Bucala; Richard J. ; et al.	2010-07-22
Mif adsorbant App 20090163599 - Storr; Markus ; et al.	2009-06-25
Anti-MIF antibodies Grant 7,517,523 - Bucala , et al. April 14, 2	2009-04-14
Soluble Cyclic Analogues Of Beta Amyloid Peptide App 20080146508 - KAPURNIOTU; Afroditi ; et al.	2008-06-19
Soluble cyclic analogues of .beta. amyloid peptide Grant 7,342,091 - Kapurniotu , et al. March 11, 2	2008-03-11
Screening method for candidate drugs Grant 7,303,885 - Brunner , et al. December 4, 2	2007-12-04
Method for determining MIF content App 20060062788 - Bucala; Richard J. ; et al.	2006-03-23
Method for determining MIF content Grant 6,998,238 - Bucala , et al. February 14, 2	2006-02-14
Soluble cyclic analogues of beta amyloid peptide App 20040116337 - Kapurniotu, Afroditi ; et al.	2004-06-17
Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity App 20040053843 - Bucala, Richard J. ; et al.	2004-03-18
Method and sample mount system for the in situ separation and enrichment of substances Grant 6,699,698 - Vitzthum , et al. March 2, 2	2004-03-02
Composition containing anti-MIF antibody Grant 6,645,493 - Bucala , et al. November 11, 2	2003-11-11
Superpotent calcitonin analogs having greatly increased hypocalcemic action in vivo Grant 6,617,423 - Kapurniotu , et al. September 9, 2	2003-09-09
Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity App 20030099653 - Bucala, Richard J. ; et al.	2003-05-29
Electrical integrated nucleic acid isolation, purification and detection Grant 6,511,831 - Bernhagen , et al. January 28, 2	2003-01-28
Device and method for isolating cell material out of a tissue medium and/or a liquid Grant 6,358,474 - Dobler , et al. March 19, 2	2002-03-19
Peptides Used As Agonists And/or Inhibitors Of Amyloid Formation And Cytotoxicity And Also For Use In Alzheimer's Disease, In Type Ii Diabetes Mellitus And In Spongiform Encephalophathies App 20010007015 - KAPURNIOTU, AFRODITI ; et al.	2001-07-05
Diagnostic assays for MIF Grant 6,080,407 - Bucala , et al. June 27, 2	2000-06-27
Combination method for treating diseases caused by cytokine-mediated toxicity Grant 6,030,615 - Bucala , et al. February 29, 2	2000-02-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.